These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 7908664

  • 1. Paclitaxel (Taxol) in breast cancer.
    Arbuck SG, Dorr A, Friedman MA.
    Hematol Oncol Clin North Am; 1994 Feb; 8(1):121-40. PubMed ID: 7908664
    [Abstract] [Full Text] [Related]

  • 2. Paclitaxel and doxorubicin in metastatic breast cancer.
    Gehl J, Boesgaard M, Paaske T, Jensen BV, Dombernowsky P.
    Semin Oncol; 1996 Dec; 23(6 Suppl 15):35-8. PubMed ID: 8996596
    [Abstract] [Full Text] [Related]

  • 3. Overview of paclitaxel (Taxol) in advanced lung cancer.
    Ettinger DS.
    Semin Oncol; 1993 Aug; 20(4 Suppl 3):46-9. PubMed ID: 8102017
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of paclitaxel or doxorubicin used as single agents in advanced breast cancer: a literature survey.
    Paridaens R.
    Semin Oncol; 1998 Oct; 25(5 Suppl 12):3-6. PubMed ID: 9865704
    [Abstract] [Full Text] [Related]

  • 5. A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer.
    Stearns V, Singh B, Tsangaris T, Crawford JG, Novielli A, Ellis MJ, Isaacs C, Pennanen M, Tibery C, Farhad A, Slack R, Hayes DF.
    Clin Cancer Res; 2003 Jan; 9(1):124-33. PubMed ID: 12538460
    [Abstract] [Full Text] [Related]

  • 6. [Taxol--a new cytostatic drug for therapy of ovarian and breast cancer].
    Meden H, Rath W, Kuhn W.
    Geburtshilfe Frauenheilkd; 1994 Apr; 54(4):187-93. PubMed ID: 7912212
    [Abstract] [Full Text] [Related]

  • 7. Paclitaxel: a new antimitotic chemotherapeutic agent.
    Gotaskie GE, Andreassi BF.
    Cancer Pract; 1994 Apr; 2(1):27-33. PubMed ID: 7914453
    [Abstract] [Full Text] [Related]

  • 8. Paclitaxel (Taxol)/doxorubicin combinations in advanced breast cancer: the Eastern Cooperative Oncology Group experience.
    Sledge GW, Robert N, Sparano JA, Cobeligh M, Goldstein LJ, Neuberg D, Rowinsky E, Baughman C, McCaskill-Stevens W.
    Semin Oncol; 1994 Oct; 21(5 Suppl 8):15-8. PubMed ID: 7939756
    [Abstract] [Full Text] [Related]

  • 9. Concurrent paclitaxel and radiation therapy for breast cancer.
    Formenti SC, Symmans WF, Volm M, Skinner K, Cohen D, Spicer D, Danenberg PV.
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):34-42. PubMed ID: 10210538
    [Abstract] [Full Text] [Related]

  • 10. Paclitaxel-containing combination chemotherapy for metastatic breast cancer.
    Hortobagyi GN, Ibrahim N.
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):53-7. PubMed ID: 8629039
    [Abstract] [Full Text] [Related]

  • 11. Taxol: initial Israeli experience with a novel anticancer agent.
    Sulkes A, Beller U, Peretz T, Shacter J, Hornreich G, McDaniel C, Winograd B.
    Isr J Med Sci; 1994 Jan; 30(1):70-8. PubMed ID: 7908013
    [Abstract] [Full Text] [Related]

  • 12. Role of paclitaxel in the treatment of breast cancer: the American Cooperative Group Experience.
    Sledge GW.
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):10-2. PubMed ID: 8629029
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel combination therapy in the treatment of metastatic breast cancer.
    Holmes FA.
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):29-39. PubMed ID: 8941408
    [Abstract] [Full Text] [Related]

  • 14. Combination paclitaxel (Taxol) and doxorubicin therapy for metastatic breast cancer.
    O'Shaughnessy JA, Fisherman JS, Cowan KH.
    Semin Oncol; 1994 Oct; 21(5 Suppl 8):19-23. PubMed ID: 7939757
    [Abstract] [Full Text] [Related]

  • 15. Treatment of metastatic breast cancer with paclitaxel and doxorubicin.
    Dombernowsky P, Gehl J, Boesgaard M, Jensen TP, Jensen BW, Ejlertsen B.
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):13-7. PubMed ID: 8643964
    [Abstract] [Full Text] [Related]

  • 16. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA.
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [Abstract] [Full Text] [Related]

  • 17. Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer.
    Lück HJ, Thomssen C, du Bois A, Untch M, Lisboa B, Köhler G, Diergarten K.
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-35-S17-39. PubMed ID: 9374090
    [Abstract] [Full Text] [Related]

  • 18. Paclitaxel doublets in metastatic breast cancer: Eastern Cooperative Oncology Group and Hoosier Oncology Group Studies.
    Sledge GW.
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):57-9. PubMed ID: 8893901
    [Abstract] [Full Text] [Related]

  • 19. Paclitaxel and carboplatin for advanced breast cancer.
    Perez EA, Hartmann LC.
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):41-5. PubMed ID: 8893899
    [Abstract] [Full Text] [Related]

  • 20. [Pharmacological action of paclitaxel].
    Potemski P, Płuzańska A.
    Pol Merkur Lekarski; 1999 Jan; 6(31):27-9. PubMed ID: 10344150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.